Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials
about
Second line drug susceptibility testing to inform the treatment of rifampin-resistant tuberculosis: a quantitative perspectiveRecent developments in the diagnosis and management of tuberculosis.Evaluation of the Antibody in Lymphocyte Supernatant Assay to Detect Active Tuberculosis.Individualizing management of extensively drug-resistant tuberculosis: diagnostics, treatment, and biomarkers.Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic ModelClinical Implications of New Drugs and Regimens for the Treatment of Drug-resistant Tuberculosis.Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis.Outcomes of multidrug-resistant tuberculosis in Zambia: a cohort analysis.Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB.Mechanisms of action and therapeutic efficacies of the lipophilic antimycobacterial agents clofazimine and bedaquiline.A Review of Moxifloxacin for the Treatment of Drug-Susceptible Tuberculosis.Aggressive Regimens Reduce Risk of Recurrence After Successful Treatment of MDR-TB.Revisiting the mutant prevention concentration to guide dosing in childhood tuberculosis.Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization?New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug development.Effect of genetic variation in UGT1A and ABCB1 on moxifloxacin pharmacokinetics in South African patients with tuberculosis.Current and developing therapies for the treatment of multi drug resistant tuberculosis (MDR-TB) in India.Of Testing and Treatment: Implications of Implementing New Regimens for Multidrug-Resistant Tuberculosis.Eligibility for shorter treatment of multidrug-resistant tuberculosis in the European Union.Management of drug-resistant tuberculosis in special sub-populations including those with HIV co-infection, pregnancy, diabetes, organ-specific dysfunction, and in the critically ill.Treatment Outcomes Associated with Multidrug-resistant TuberculosisShorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcer
P2860
Q28074085-67E9E4A3-4288-4378-9542-EA12D487B7D3Q28077124-0FE70D39-6EF0-46CB-8CFA-15339A1976EBQ30275004-53586C0E-C2E7-4821-A298-F22D94621168Q30275673-DC51987A-52F6-4CA8-B655-8D6D5535C5BFQ30379233-A5E73307-036E-4CEC-99BC-EDA10892A308Q33760793-0EA9103F-C481-4424-A394-8F584412BAE0Q37675764-CB935B54-4ACB-4AB1-964F-37697FBAF659Q38639403-64CC1FD5-ABF4-4232-96D5-CCAC3E55C0C5Q38973113-6932ECE3-0591-4179-9260-55EF92BC09BEQ38995175-BD937EA9-F500-4873-B7F8-7E5BFFA987B5Q39456569-7A1E8B8A-5E8A-49FC-B551-071CB1C830A6Q39780875-4F4E721C-8E1D-4C6A-BAA5-A8E57BC63BA7Q40282057-CAC99EE8-DACF-4C82-A007-84C16AA48310Q47332682-765BB3CF-CD72-416E-B918-4F352124B031Q47594312-7ACAE440-DAA9-473E-8A2D-54391D0A76DFQ50054098-3F9C8633-B131-400D-8A98-4345065FA5B2Q50508187-B7E3C0D4-92CC-4A4A-8DE0-A699ED8E231DQ52648707-6367091F-FECD-4B54-9AD0-B38631928F68Q54005515-B7B93958-E4D4-4B2E-9BB1-85F810534C8BQ55547799-7E956D6D-7AE1-46F3-8C79-B7DD46B2418FQ57922788-C833EC4B-243E-4555-BAF9-1A32D963AA30Q58785246-F6418DB7-6E81-4CF3-9126-87BC2AA745F7
P2860
Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials
@ast
Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials
@en
Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials
@nl
type
label
Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials
@ast
Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials
@en
Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials
@nl
prefLabel
Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials
@ast
Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials
@en
Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials
@nl
P1476
Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials
@en
P2093
Riya Moodley
Thomas R Godec
P356
10.1183/16000617.0080-2015
P407
P577
2016-03-01T00:00:00Z